Ranger® Technology offers industry-leading scalability and precision for the size selection process, ensuring maximal enrichment, every time.
Core automated size selection functionality is complemented by the ability to perform fragment length analysis and fluorescence assays for next-generation sequencing (NGS) quality control applications. Ranger® Technology has so far been deployed to power multiple solutions across our instrumentation portfolio, with applications from liquid biopsy to non-invasive prenatal testing (NIPT) and beyond.
The LightBench® Detect is designed specifically for clinical liquid biopsy applications, and leverages patent-pending technology to enable greater flexibility in blood tube collection choice.
The NIMBUS Select, is the solution of choice for our partners with higher throughput requirements.
The Yourgene QS250 is available exclusively for clinical grade use in Yourgene’s NIPT workflows.
Why Choose Ranger®
The proprietary method for electrophoretic mobility assessment used by Ranger® Technology enables it to control that mobility through real-time voltage manipulation. This control is exercised continuously until the target DNA fraction has arrived at a point in the gel cassette from which it can be extracted. When that is achieved, Ranger® Technology initiates the extraction process, ensuring the precise target DNA fragment lengths are recovered over multiple samples..
Fragment Analyzer (Advanced Analytical Technologies) evaluation of small RNA libraries that have gone through size selection with Ranger Technology. A target range of 130bp to 150bp was set for each sample, and each sample was processed repeatably despite differences between the samples that led to varied electrophoretic mobilities. (Image courtesy of Dr. J. Russ Carmical, Center for Metagenomics & Microbiome Research, Baylor College of Medicine).
Accurate Fragment Length Estimation
Throughout the electrophoretic documentation process, Ranger® Technology captures images to record the mobility of DNA in the sample. During each imaging sequence photos are taken with a blue excitation lights, and then another with red excitation lights. The blue images reveal the location of all DNA in the sample. The red images reveal only the location of internal reference markers, which are exclusively labelled with a secondary fluorophore.
This two-colour system allows Ranger® Technology to leverage reference markers that are close in size to the desired DNA size range of interest. The internal reference markers are always identified by Ranger® Technology’s machine vision suite, regardless of overlap with DNA fragments of similar length. Yourgene Health supports a variety of different internal reference marker sizes that users can select from to optimize the performance of the platform for specific assays.
High Recovery Yields
Ranger® Technology combines accurate fragment length estimation and controlled migration of DNA to ensure that the recovery operation is conducted over the entire span of the target fragment lengths. Our internal testing reveals that recovery yields are consistently over 70%. Extraction volumes can be kept to under 35 ul volumes to ensure high concentration of DNA for downstream processing.
Ranger® Technology recovered all fragments between 70bp and 190 bp from a 20 bp dsDNA ladder (Lonza). Comparison of the electrophoretic traces of the input and size selected fraction indicate an average recovery yield of 73% across all targeted fragment sizes. Further tests involving solution-based fluorometric assays confirm recovery yields to be in excess of 70% (data not shown).